Sharps Technology Inc SEC Filings

Paul K. Danner, a director of Sharps Technology Inc. (STSS), was granted options to purchase 400,000 shares at an exercise price of $6.41 per share. The grant was reported with a transaction date of 08/22/2025 and the option is scheduled to become 100% vested and exercisable on May 22, 2026. Following the reported transaction, Mr. Danner beneficially owns 400,000 shares subject to the option on a direct basis. The grant was made pursuant to the company's 2025 Equity Incentive Plan.

Brenda Baird Simpson, a director of Sharps Technology Inc. (ticker: STSSW), was granted a non‑derivative option to purchase 20,000 shares on 08/22/2025 at an exercise price of $6.41 per share. The option was granted under the company’s 2025 Equity Incentive Plan and "will become 100% vested as of the date of issuance," per the filing. Following the grant, Ms. Simpson directly beneficially owns 20,000 shares/options reported on this Form 4.

Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP and Altium Healthcare Long Short GP LLC jointly report beneficial ownership of 35,659 shares of Sharps Technology Inc. common stock issuable upon conversion of Series A warrants, representing 3.48% of the class based on 1,023,214 shares outstanding.

The filing notes the Series A warrants are subject to a 9.99% Warrant Blocker that prevents exercise to the extent it would raise ownership above that threshold. The cover-page figures include the full number of shares issuable on conversion and do not give effect to the Warrant Blocker, so the actual number of shares the reporting persons could beneficially own after giving effect to the blocker is less than the reported amount. Reported sole voting and dispositive power are 0, with 35,659 shared voting and dispositive power.

Sharps Technology, Inc. reported its first product revenue in the quarter of $222,722 and recorded a gross loss of $1,032,027 primarily driven by cost of goods and an inventory reserve. Total assets rose to $17,085,197 and cash increased to $8,322,192, reflecting net proceeds of approximately $18.2 million from a January 2025 equity offering and partial repayment of debt.

For the six months ended June 30, 2025 the company reported net income of $5,488,141, largely attributable to a noncash fair‑value gain on warrants of $11,087,700; warrant liabilities were $1,312,848 at period end. Management discloses substantial doubt about going concern and expects to seek additional financing. The filing also discloses legal claims including a lawsuit alleging up to $1.762 million and an arbitration claim of $500,000, plus equipment purchase commitments of approximately $4.7 million.